Newport Hospital Launches 3-D Breast Mammography

July 14, 2016

TomosynthesisNewport Hospital is now offering 3-D mammography, also called digital breast tomosynthesis, that takes multiple three-dimensional images of the breasts in layers. These high-clarity pictures allow physicians to better evaluate a patient and improve the identification of tumors. The technology is key to early detection of cancer and decreases false positives – which occur when an abnormal area on an x-ray is determined to not be cancer – and the number of necessary diagnostic mammograms.

“As a breast imaging Center of Excellence, Newport Hospital is committed to providing the latest innovations in women’s health care,” said Crista F. Durand, president of Newport Hospital. “By producing more accurate images, tomosynthesis helps to pinpoint the size and location of any abnormality, making this technology a critical benefit to our patients.”

The 3-D mammogram can be used for diagnostics and screening for all women, including those with dense breasts for whom it can be more difficult to detect breast cancer through standard mammograms. It is available at Newport Hospital and Portsmouth Imaging Center. For questions about tomosynthesis, please call 401-444-7770.

“We are sincerely grateful to BankNewport for their leadership gift which was instrumental to Newport Hospital adding tomosynthesis mammography to our list of available services offered,” said Loriana De Crescenzo, chief development officer. “The women's imaging section of radiology at Newport Hospital is one of only four American College of Radiology accredited Breast Imaging Centers of Excellence recognized in Rhode Island. The purchase of tomosynthesis equipment will allow us to maintain our standing as one of the state’s top women’s imaging centers, and we wish to recognize BankNewport for their partnership and generous support which makes it possible for us to deliver health with care.”

Breast cancer is the most common cancer in U.S. women except for skin cancer and remains the second leading cause of cancer death among women overall, according to the Centers for Disease Control and Prevention (CDC). In 2-D mammography, breast cancers can be hidden behind normal breast tissues, or shadows can create false positives. In recent studies, tomosynthesis found 1.3 cancers per 1,000 examinations not found by conventional mammography. It also reduced callbacks for diagnostic mammograms by 20 percent on average and as much as 30 percent in some studies

Elena Falcone-Relvas

Senior Public Relations Officer
Bradley Hospital & Hasbro Children's Hospital